# Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

> **NCT01010399** · PHASE4 · COMPLETED · sponsor: **Felizarta, Franco, M.D.** · enrollment: 36 (actual)

## Conditions studied

- Hypertriglyceridemia
- HIV Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lovaza
- **DRUG:** fosamprenavir/ritonavir

## Key facts

- **NCT ID:** NCT01010399
- **Lead sponsor:** Felizarta, Franco, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010399, "Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01010399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*